Two major Indian pharmaceutical companies, Dr Reddy's Laboratories and Zydus Lifesciences, are recalling certain medicines from the US market due to manufacturing issues, the US health regulator has said.
According to the latest enforcement report by the US Food and Drug Administration (USFDA), an American subsidiary of Hyderabad-based Dr Reddy’s is recalling 571 vials of Succinylcholine Chloride Injection, a medicine used to relax muscles.
The recall was initiated on September 26 after the USFDA reported an “out-of-specification result during six-month stability testing.”
The affected batch is being withdrawn nationwide in the United States as a Class II recall, which indicates that exposure to the product may cause temporary or reversible health problems, but serious health issues are